Scarica l'app Stockscreener
23.42
0.85%
-0.20
Dopo l'orario di chiusura:
23.40
-0.02
-0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$23.62
Aprire:
$23.36
Volume 24 ore:
680.83K
Relative Volume:
0.80
Capitalizzazione di mercato:
$1.17B
Reddito:
$290.38M
Utile/perdita netta:
$-21.03M
Rapporto P/E:
-54.54
EPS:
-0.4294
Flusso di cassa netto:
$-54.99M
1 W Prestazione:
-0.66%
1M Prestazione:
-6.77%
6M Prestazione:
+35.93%
1 anno Prestazione:
-15.33%
Intervallo 1D:
$23.02
$23.74
Intervallo di 1 settimana:
$22.66
$24.36
Portata 52W:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
23.42 | 1.18B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | Iniziato | Wedbush | Neutral |
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Finviz
U.S. laser procedures fell 52% as use of implantable lenses rose 76% - Stock Titan
STAA Looks 29.6% Undervalued on GF Value™ - GuruFocus
Ex-STAAR Surgical CEO David Bailey Rejoins as Chief Commercial Officer - Medical Product Outsourcing
Former CEO returns as STAAR's vision-lens revenue grows more than tenfold - Stock Titan
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more - Glance by Eyes On Eyecare
STAA Looks 27.7% Undervalued on GF Value™ - GuruFocus
Why Did STAA Stock Surge More Than 19% After-Hours Today? - Stocktwits
STAAR Surgical names Ben Park as CTO - medicalbuyer.co.in
STAAR Surgical Appoints Ben Park as Chief Technology Officer - VisionMonday.com
STAAR Surgical Hires Align Exec Dr. Ben Park as CTO - Medical Product Outsourcing
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer - Business Wire
STAAR Surgical Company Announces Appointment of Ben Park as Chief Technology Officer - marketscreener.com
Is STAAR Surgical (STAA) Cheap Following Its Recent Share Price Slide? - simplywall.st
STAAR Surgical Company (STAA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
STAAR Surgical Names Warren Foust President and Chief Executive Officer - thekeyexecutives.com
Madison Avenue Partners, LP Buys Staar Surgical Co (STAA) -- Sha - GuruFocus
STAAR (STAA) Q2 2026 Earnings Call Transcript - The Globe and Mail
5 Insightful Analyst Questions From STAAR Surgical’s Q2 Earnings Call - Yahoo Finance
STAAR Surgical CEO Warren Foust Reports PSU Vesting and New Equity Grants on August 14, 2026 - Kalkine Media
STAAR Surgical CFO Deborah Andrews Reports August 2026 Stock Vesting and New Equity Grants - Kalkine Media
STAAR Surgical (STAA) awards CFO RSUs, options and PSUs - Stock Titan
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
Midday Stock Roundup: Indie Semi Falls - Orange County Business Journal
Why STAAR Surgical (STAA) Shares Are Sliding Today - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade - MarketBeat
Deciphering Staar Surgical (STAA) International Revenue Trends - Yahoo Finance
Stifel cuts Staar Surgical stock price target on China concerns By Investing.com - Investing.com Australia
Stifel cuts Staar Surgical stock price target on China concerns - Investing.com
Stifel Nicolaus Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $28.00 - MarketBeat
Staar Surgical Appoints Warren Foust as President and CEO - Eyewire+
Is STAAR Surgical (STAA) Still Below Fair Value After Its Return To Profit? - Yahoo Finance
Why STAAR Surgical (STAA) Is Up 8.1% After Returning To Profit Under New CEO Warren Foust – And What's Next - simplywall.st
STAA Q2 Deep Dive: China Demand and Product Expansion Drive Revenue Growth Amid Market Caution - Yahoo Finance
Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment - Yahoo Finance
STAAR Surgical (STAA) Gives Warren Foust The CEO Role After Its Profit Reset - Yahoo Finance
STAAR Surgical (STAA) Stock May Be 13% Below Fair Value Following Q2 Earnings Preview - Yahoo Finance
Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA - MarketBeat
Staar Surgical Co (STAA) Shares Surge 3.4% -- What GF Score of 8 - GuruFocus
STAAR Surgical (STAA) reports 8.4% stake held by Madison Avenue group - Stock Titan
STAAR Surgical (STAA) Stock Price Shrugs Off Profit Rebound As China Dominates - simplywall.st
STAAR Surgical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Jefferies cuts STAAR Surgical stock price target on estimate update By Investing.com - Investing.com South Africa
STAA Maintains Rating by UBS -- Price Target Lowered to $19.00 - GuruFocus
Jefferies cuts STAAR Surgical stock price target on estimate update - Investing.com
STAA Maintained by Wedbush -- Price Target Lowered to $37.00 - GuruFocus
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 By Investing.com - Investing.com South Africa
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 - Investing.com
STAAR Surgical (NASDAQ:STAA) Price Target Lowered to $37.00 at Wedbush - MarketBeat
STAAR Surgical Company Q2 2026 Earnings Call Summary - Yahoo Finance
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):